Parkman Healthcare Partners LLC Gossamer Bio, Inc. Transaction History

Parkman Healthcare Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$5.97 - $9.97 $1.2 Million - $2 Million	-200,185 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$8.44 - $12.49 $2.92 Million - $4.32 Million	-346,236 Reduced 63.36%	200,185 $1.74 Million
Q4 2021 Feb 11, 2022	SELL	$10.12 - $14.07 $2.43 Million - $3.38 Million	-240,449 Reduced 30.56%	546,421 $6.18 Million
Q2 2021 Aug 13, 2021	BUY	$8.0 - $9.75 $1.63 Million - $1.99 Million	203,980 Added 34.99%	786,870 $6.39 Million
Q1 2021 May 14, 2021	BUY	$8.63 - $10.94 $2 Million - $2.54 Million	232,111 Added 66.17%	582,890 $5.39 Million
Q4 2020 Feb 12, 2021	BUY	$8.3 - $13.59 $2.91 Million - $4.77 Million	350,779 New	350,779 $3.39 Million

112

168M

450K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $99.6M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.